Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

J. Michael Gaziano, M.D.

Co-Author

This page shows the publications co-authored by J. Gaziano and Edward Giovannucci.
Connection Strength

2.936
  1. Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):419-424.e1.
    View in: PubMed
    Score: 0.136
  2. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011 Apr 06; 6(4):e18625.
    View in: PubMed
    Score: 0.121
  3. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1099-106.
    View in: PubMed
    Score: 0.066
  4. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr. 2001 Oct; 74(4):549-54.
    View in: PubMed
    Score: 0.063
  5. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. 2021 Jul 13.
    View in: PubMed
    Score: 0.062
  6. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Cancer Res. 2021 Jun 01; 81(11):3134-3143.
    View in: PubMed
    Score: 0.060
  7. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. J Natl Cancer Inst. 2020 10 01; 112(10):1003-1012.
    View in: PubMed
    Score: 0.059
  8. Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal Women. Hepatology. 2020 08; 72(2):535-547.
    View in: PubMed
    Score: 0.058
  9. Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank. Br J Cancer. 2020 07; 123(2):316-324.
    View in: PubMed
    Score: 0.057
  10. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. Int J Cancer. 2020 08 01; 147(3):675-685.
    View in: PubMed
    Score: 0.055
  11. Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1868-1875.
    View in: PubMed
    Score: 0.054
  12. Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). Int J Epidemiol. 2018 12 01; 47(6):1760-1771.
    View in: PubMed
    Score: 0.052
  13. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. Am J Gastroenterol. 2018 10; 113(10):1494-1505.
    View in: PubMed
    Score: 0.051
  14. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018 04; 118(7):1005-1012.
    View in: PubMed
    Score: 0.049
  15. Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). J Natl Cancer Inst. 2018 01 01; 110(1).
    View in: PubMed
    Score: 0.048
  16. Cigarette Smoking and Pancreatic Cancer Survival. J Clin Oncol. 2017 Jun 01; 35(16):1822-1828.
    View in: PubMed
    Score: 0.046
  17. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. Am J Epidemiol. 2017 03 15; 185(6):452-464.
    View in: PubMed
    Score: 0.046
  18. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Cancer Res. 2016 12 15; 76(24):7160-7167.
    View in: PubMed
    Score: 0.045
  19. Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Gut. 2017 06; 66(6):1116-1122.
    View in: PubMed
    Score: 0.045
  20. Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults. Cancer Res. 2016 10 15; 76(20):6076-6083.
    View in: PubMed
    Score: 0.044
  21. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. 2016 Oct 11; 7(41):66328-66343.
    View in: PubMed
    Score: 0.044
  22. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. J Clin Oncol. 2016 08 20; 34(24):2899-905.
    View in: PubMed
    Score: 0.043
  23. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun. 2016 06 13; 7:11843.
    View in: PubMed
    Score: 0.043
  24. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nat Commun. 2016 Apr 07; 7:10979.
    View in: PubMed
    Score: 0.043
  25. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. J Natl Cancer Inst. 2016 Jun; 108(6):djv409.
    View in: PubMed
    Score: 0.042
  26. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
    View in: PubMed
    Score: 0.041
  27. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prev Res (Phila). 2015 Dec; 8(12):1156-62.
    View in: PubMed
    Score: 0.041
  28. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev. 2015 Sep; 24(9):1398-406.
    View in: PubMed
    Score: 0.041
  29. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97.
    View in: PubMed
    Score: 0.040
  30. A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol. 2015 Apr; 67(4):649-57.
    View in: PubMed
    Score: 0.039
  31. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014 10; 20(10):1193-1198.
    View in: PubMed
    Score: 0.039
  32. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014 Sep; 46(9):994-1000.
    View in: PubMed
    Score: 0.038
  33. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.038
  34. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. J Natl Cancer Inst. 2014 Jun; 106(6):dju085.
    View in: PubMed
    Score: 0.038
  35. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol. 2014 Sep; 166(5):667-76.
    View in: PubMed
    Score: 0.038
  36. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol. 2014 Jun; 65(6):1069-75.
    View in: PubMed
    Score: 0.037
  37. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One. 2013; 8(9):e72311.
    View in: PubMed
    Score: 0.036
  38. Hyperglycemia, insulin resistance, impaired pancreatic ß-cell function, and risk of pancreatic cancer. J Natl Cancer Inst. 2013 Jul 17; 105(14):1027-35.
    View in: PubMed
    Score: 0.035
  39. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet. 2013 Mar 23; 381(9871):1029-36.
    View in: PubMed
    Score: 0.035
  40. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):855-61.
    View in: PubMed
    Score: 0.035
  41. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):688-96.
    View in: PubMed
    Score: 0.034
  42. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst. 2013 Jan 16; 105(2):95-103.
    View in: PubMed
    Score: 0.034
  43. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2012 Dec 15; 176(12):1121-9.
    View in: PubMed
    Score: 0.034
  44. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut. 2014 Jan; 63(1):152-60.
    View in: PubMed
    Score: 0.034
  45. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control. 2013 Jan; 24(1):13-25.
    View in: PubMed
    Score: 0.034
  46. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8.
    View in: PubMed
    Score: 0.033
  47. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis. 2012 Jul; 33(7):1384-90.
    View in: PubMed
    Score: 0.033
  48. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2012 May 01; 175(9):926-35.
    View in: PubMed
    Score: 0.032
  49. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):437-44.
    View in: PubMed
    Score: 0.032
  50. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet. 2011 Oct 01; 20(19):3867-75.
    View in: PubMed
    Score: 0.031
  51. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One. 2011 Feb 24; 6(2):e17142.
    View in: PubMed
    Score: 0.030
  52. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3140-9.
    View in: PubMed
    Score: 0.029
  53. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer. 2010 Sep 01; 127(6):1421-8.
    View in: PubMed
    Score: 0.029
  54. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2877-87.
    View in: PubMed
    Score: 0.029
  55. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab. 2010 Sep; 95(9):E121-7.
    View in: PubMed
    Score: 0.029
  56. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet. 2010 Aug 01; 19(15):3089-101.
    View in: PubMed
    Score: 0.029
  57. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010 May 10; 170(9):791-802.
    View in: PubMed
    Score: 0.028
  58. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010 Feb 01; 70(3):1015-23.
    View in: PubMed
    Score: 0.028
  59. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010 Mar; 42(3):224-8.
    View in: PubMed
    Score: 0.028
  60. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis. 2010 Mar; 31(3):455-61.
    View in: PubMed
    Score: 0.028
  61. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2734-44.
    View in: PubMed
    Score: 0.027
  62. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009 Sep; 41(9):986-90.
    View in: PubMed
    Score: 0.027
  63. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet. 2009 Oct 01; 18(19):3749-57.
    View in: PubMed
    Score: 0.027
  64. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):7933-8.
    View in: PubMed
    Score: 0.026
  65. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008 Nov; 9(11):1039-47.
    View in: PubMed
    Score: 0.025
  66. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):1973-81.
    View in: PubMed
    Score: 0.024
  67. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 2007 Apr 01; 67(7):2951-6.
    View in: PubMed
    Score: 0.023
  68. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007 Mar; 4(3):e103.
    View in: PubMed
    Score: 0.023
  69. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005 12; 5(12):977-85.
    View in: PubMed
    Score: 0.021
  70. Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet. 2005 Nov; 1(5):e68.
    View in: PubMed
    Score: 0.021
  71. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res. 2005 Mar 15; 65(6):2498-504.
    View in: PubMed
    Score: 0.020
  72. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst. 2004 May 05; 96(9):696-703.
    View in: PubMed
    Score: 0.019
  73. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst. 2004 Apr 07; 96(7):546-53.
    View in: PubMed
    Score: 0.019
  74. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst. 2001 Sep 05; 93(17):1330-6.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.